Abstract
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-Developed by VHIO, a novel AI-based and non-invasive diagnostic tool enables accurate brain tumor diagnosis, outperfor ming current classification methods Jointly developed by investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group and the Bellvitge University Hospital's Neuroradiology Un it, the Diagnosis in Susceptibility Contrast Enhancing Regions for Neuroncology (DISCERN) is an open access, deep learning tool based on the training of pattern s using artificial intelligence models from information of standard magnetic res onance imaging (MRI). Published in the journal Cell Reports Medicine*, results of a VHIO-led study demonstrate the feasibility and accuracy of DISCERN as an ena bler of accurate brain tumor diagnosis from perfusion MRI, outperforming convent ional methods.
NETL
NSTL